Molecular Farming Potential to Be Disruptive in the Alternative Protein Landscape

Molecular farming, also known as plant-made pharmaceuticals (PMPs) or pharming, is a technology that involves using plants to produce pharmaceuticals, industrial products, and other substances. This approach has the potential to be a more sustainable and cost-effective alternative to traditional methods of producing these products, which often rely on chemical synthesis or animal-based production. In molecular farming, plants are genetically modified to produce a desired protein or other substance. These plants can then be harvested, and the desired product can … Continue reading “Molecular Farming Potential to Be Disruptive in the Alternative Protein Landscape”

Molecular Volatility in Newly Public Agritech Moolec Science Fuels 250% Price Swings

Agritech Molecular farming company Moolec Science completed a merger with a special purpose acquisition company (SPAC) on December 30, 2022. The Luxembourg company began trading Tuesday January 3, 2003 on the NASDAQ under the symbol MLEC.  Moolec Science Ltd. and LightJump Acquisition Corporation closed their business combination agreement which saw Moolec UK and LightJump become wholly owned subsidiaries of Moolec Science SA. Moolec uses genetically modified plants to produce proteins that are found in animals. The deal values Moolec at $504 … Continue reading “Molecular Volatility in Newly Public Agritech Moolec Science Fuels 250% Price Swings”